CN104736518B - 制备噻二唑的方法 - Google Patents

制备噻二唑的方法 Download PDF

Info

Publication number
CN104736518B
CN104736518B CN201380026364.0A CN201380026364A CN104736518B CN 104736518 B CN104736518 B CN 104736518B CN 201380026364 A CN201380026364 A CN 201380026364A CN 104736518 B CN104736518 B CN 104736518B
Authority
CN
China
Prior art keywords
alkyl
substituted
naphthyl
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380026364.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN104736518A (zh
Inventor
E.A.贝尔科特
M.拜奥
J.钱
J.科利尔
Y.方
S.门嫩
R.R.米尔本
J.特德罗
B.里亚海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CN104736518A publication Critical patent/CN104736518A/zh
Application granted granted Critical
Publication of CN104736518B publication Critical patent/CN104736518B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
CN201380026364.0A 2012-05-18 2013-05-17 制备噻二唑的方法 Expired - Fee Related CN104736518B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261648928P 2012-05-18 2012-05-18
US61/648,928 2012-05-18
PCT/US2013/041504 WO2013173672A1 (en) 2012-05-18 2013-05-17 Method for the preparation of thiadiazoles

Publications (2)

Publication Number Publication Date
CN104736518A CN104736518A (zh) 2015-06-24
CN104736518B true CN104736518B (zh) 2017-10-13

Family

ID=49584318

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380026364.0A Expired - Fee Related CN104736518B (zh) 2012-05-18 2013-05-17 制备噻二唑的方法

Country Status (7)

Country Link
US (2) US9296735B2 (enExample)
EP (1) EP2850057A4 (enExample)
JP (1) JP6177894B2 (enExample)
CN (1) CN104736518B (enExample)
CA (1) CA2877026A1 (enExample)
IN (1) IN2014KN02683A (enExample)
WO (1) WO2013173672A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104788419B (zh) * 2014-12-30 2018-12-21 西华大学 手性(2,2-二甲基-1,3二氧环戊烷-4-基)羟基甲磺酸盐及其制备方法和应用
PY19106036A (es) 2018-12-20 2021-07-06 Bayer Ag Compuestos de heterociclil piridazina como fungicidas
AU2021291371A1 (en) 2020-06-18 2023-02-02 Bayer Aktiengesellschaft Active compound combinations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101671267A (zh) * 2009-09-30 2010-03-17 浙江理工大学 一种直接将醛或脂肪族甲基酮的亚硫酸氢钠加成产物转变为相应肟的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2544562A (en) * 1947-07-18 1951-03-06 Stanolind Oil & Gas Co Process for recovering aldehydes and ketones
DK36784A (da) * 1983-02-25 1984-08-26 Hoffmann La Roche Fremgangsmaade til fremstilling af chirale aldehyder
DE19847823A1 (de) * 1998-10-16 2000-04-20 Aventis Pharma Gmbh Substituierte Thiadiazolsulfonamide
JP4144978B2 (ja) 1999-09-09 2008-09-03 富士フイルム株式会社 1,2,4−チアジアゾール誘導体の合成法
NZ567858A (en) 2005-11-01 2011-08-26 Array Biopharma Inc Pyridine compounds useful as Glucokinase activators
ES2378704T3 (es) 2006-01-27 2012-04-17 Array Biopharma, Inc. Activadores de la glucocinasa
CA2647208C (en) 2006-03-24 2014-05-13 Array Biopharma Inc. Glucokinase activators
US8431713B2 (en) 2007-01-24 2013-04-30 Array Biopharma, Inc. 2-aminopyridine derivatives as glucokinase activators
EP2173745A2 (en) 2007-03-23 2010-04-14 Array Biopharma, Inc. 2-aminopyridine analogs as glucokinase activators
ES2393824T3 (es) * 2007-09-21 2012-12-28 Array Biopharma, Inc. Derivados de piridin-2-il-amino-1,2,4-tiadiazol como activadores de glucoquinasa para el tratamiento de diabetes mellitus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101671267A (zh) * 2009-09-30 2010-03-17 浙江理工大学 一种直接将醛或脂肪族甲基酮的亚硫酸氢钠加成产物转变为相应肟的方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
New General Method for Regio- and Stereoselective Allylic Substitution with Aryl and Alkenyl Coppers Derived from Grignard Reagent;Yohei Kiyotsukae et al.;《J. Org. Chem.》;20090206;第74卷;1939-1951 *
Synthesis of 2,3-O-isopropylidene-D-glyceraldehyde in High Chemical and Optical Purity: Observations on the Development of a Practical Bulk Process;Christopher R. Schmid et al.;《J. Org. Chem.》;19811231;第56卷;4056-4058 *

Also Published As

Publication number Publication date
EP2850057A1 (en) 2015-03-25
US20160221985A1 (en) 2016-08-04
JP2015517531A (ja) 2015-06-22
CA2877026A1 (en) 2013-11-21
US9296735B2 (en) 2016-03-29
CN104736518A (zh) 2015-06-24
WO2013173672A1 (en) 2013-11-21
US20150141655A1 (en) 2015-05-21
IN2014KN02683A (enExample) 2015-05-08
EP2850057A4 (en) 2016-01-27
JP6177894B2 (ja) 2017-08-09

Similar Documents

Publication Publication Date Title
AU2019208331B2 (en) Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
AU2006249065B2 (en) Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
RU2409570C2 (ru) Производные триазола
JP2015506923A (ja) RORcモジュレーターとしてのベンジルスルホンアミド誘導体
AU2005236020A1 (en) 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
ZA200605747B (en) Production method
CA2634198A1 (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
CN104736518B (zh) 制备噻二唑的方法
BRPI0616457A2 (pt) derivados de fenil-1,2 oxadiazolona com grupo fenila, bem como seu uso, composição farmacêutica compreendendo os mesmos e seu processo de preparação
BRPI0718714B1 (pt) Arilamidas substituídas por tiazol e oxazol, seu uso e composição farmacêutica que as compreende
BRPI0716996B1 (pt) processo para preparar um composto
JP2016510781A (ja) RORcモジュレーターとしてのアリールスルファミド及びスルファミン酸誘導体
EP2342177A1 (en) Novel potassium channel blockers
CA2729408A1 (en) Triazole derivative or salt thereof
AU2003226757A1 (en) Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
JP2012512222A (ja) チアジアゾール置換アリールアミド
US20100105657A1 (en) Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
SK492001A3 (en) Biphenyl derivatives
US20040186108A1 (en) Phenylalkyl and pyridylalkyl piperazine derivatives
WO2016116058A1 (zh) 一种具有杀线虫活性的三嗪杂环化合物及其制法和用途
AU2005301626A1 (en) Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
Hassan et al. New access to pyrazole, oxa (thia) diazole and oxadiazine derivatives
AU2020407604A1 (en) 4-phenyl-n-(phenyl)thiazol-2-amine derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of e.g. angiogenesis implicated or inflammatory disorders
CN111699184B (zh) 噁唑烷酮化合物的制造方法
CA2892919A1 (en) Process for making reverse transcriptase inhibitors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171013

Termination date: 20190517

CF01 Termination of patent right due to non-payment of annual fee